Back to Search
RICHARD STONE, M.D.
M.D.
Dermatology Physician
NPI: 1548262801IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
154114-1205(UT)
Procedural Dermatology Physician
Dermatology — Procedural Dermatology
Code: 207NS0135X
154114-1205(UT)
Dermatopathology Physician
Dermatology — Dermatopathology
Code: 207ND0900X
154114-1205(UT)
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 1970
Research & Publications (20)
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.
PMID 18670778·Cancer Chemother Pharmacol·2009
3-trial
Timed sequential induction chemotherapy in AML: time for reflection.
PMID 18828158·Am J Hematol·2008
8-other
Are new agents really making a difference in MDS?
PMID 19041603·Best Pract Res Clin Haematol·2008
6-review
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
PMID 18756547·Am J Hematol·2008
3-trial
The place of assisted living in long-term care and related service systems.
PMID 18162566·Gerontologist·2007
6-review
Introduction: the role of training and education in solving the direct care workforce crisis.
PMID 18032188·Gerontol Geriatr Educ·2007
8-other
Associations between childhood refraction and parental smoking.
PMID 17003416·Invest Ophthalmol Vis Sci·2006
8-other
Physician involvement in long-term care: bridging the medical and social models.
PMID 16979093·J Am Med Dir Assoc·2006
8-other
Anterior segment growth and peripheral neural pathways in chick.
PMID 16769610·Curr Eye Res·2006
7-preclinical
Local patterns of image degradation differentially affect refraction and eye shape in chick.
PMID 16421023·Curr Eye Res·2006
7-preclinical
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.
PMID 15345597·Blood·2005
3-trial
Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome.
PMID 15175999·Semin Oncol·2004
6-review
Optimizing treatment of chronic myeloid leukemia: a rational approach.
PMID 15169981·Oncologist·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 N UNIVERSITY AVE STE 23
PROVO, UT 84604 - Phone
- (801) 377-4745
Quick Facts
- NPI
- 1548262801
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 56
- Publications
- 20
Are you this provider?
Claim Your Profile